Related Experiment Video
Updated: Aug 8, 2025
08:13
Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
68.9K
Gestational diabetes mellitus: a growing economic concern
Radiana Staynova1, Emanuela Vasileva1, Vesselina Yanachkova2
1Medical University of Plovdiv, Plovdiv, Bulgaria.
Folia Medica
|March 6, 2023
Summary
Gestational diabetes mellitus (GDM) is a growing global health concern. More research is needed on the economic impact of GDM pregnancies to inform healthcare costs and management strategies.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Health Economics
Background:
- Gestational diabetes mellitus (GDM) is a frequent complication during pregnancy.
- Epidemiological data indicate a global rise in GDM prevalence.
- GDM is linked to adverse pregnancy outcomes and increased healthcare expenditures.
Purpose of the Study:
- To highlight the increasing global prevalence of gestational diabetes mellitus (GDM).
- To underscore the association between GDM and adverse pregnancy outcomes.
- To emphasize the need for pharmacoeconomic evaluations of GDM-affected pregnancies.
Main Methods:
- Review of recent epidemiological data on GDM prevalence.
- Analysis of the relationship between GDM and pregnancy outcomes.
- Identification of the gap in pharmacoeconomic research for GDM.
Main Results:
- GDM prevalence is increasing worldwide.
- GDM is associated with adverse pregnancy outcomes.
- There is a scarcity of pharmacoeconomic studies on GDM pregnancies.
Conclusions:
- The rising prevalence of GDM necessitates further investigation into its economic burden.
- Pharmacoeconomics is crucial for managing healthcare costs associated with GDM.
- More studies are required to evaluate the expenses of pregnancies impacted by GDM.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
01:20Pathophysiology of Diabetes
1.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
01:15Diabetes: Symptoms, Diagnosis, and Complications
625
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
625
01:22Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
250
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
250
01:15Hypoglycemia and Glucagon
308
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
308